1995
DOI: 10.1016/0223-5234(96)88254-7
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and anticonvulsant activity of some 4-nitro-N-phenylbenzamides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
6
0

Year Published

1996
1996
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 9 publications
0
6
0
Order By: Relevance
“…According top hase1of the anticonvulsants creening project(ASP),twoconvulsantt ests,maximale lectroshock( MES)and pentylenetetrazole (ScPTZ),a reused forprimary evaluation foranticonvulsantactivity and the rotarod test isu sed forprimary toxicity screening [28].The anticonvulsantactivity of the title compounds wasdetermined against MES seizuresduetothe reported datarevealing the anti-MES activity of anilide pharmacophore [9][10][13][14][15][16][17][18][19].The MES test isamodel forgeneralized tonic-clonicseizuresand represents the compoundspreventing seizurespreads [28].The activity dataof the title compoundsagainst MES seizuresinduced 0.5 and 4h afteradministration atasingle dose level of 100 mg/kg aresummarized in Table 4. Also,the primary neurologicaltoxicity of the compoundsdetermined byt he rotarod test ispresented in Table 4.…”
Section: 2anticonvulsantactivitymentioning
confidence: 99%
See 1 more Smart Citation
“…According top hase1of the anticonvulsants creening project(ASP),twoconvulsantt ests,maximale lectroshock( MES)and pentylenetetrazole (ScPTZ),a reused forprimary evaluation foranticonvulsantactivity and the rotarod test isu sed forprimary toxicity screening [28].The anticonvulsantactivity of the title compounds wasdetermined against MES seizuresduetothe reported datarevealing the anti-MES activity of anilide pharmacophore [9][10][13][14][15][16][17][18][19].The MES test isamodel forgeneralized tonic-clonicseizuresand represents the compoundspreventing seizurespreads [28].The activity dataof the title compoundsagainst MES seizuresinduced 0.5 and 4h afteradministration atasingle dose level of 100 mg/kg aresummarized in Table 4. Also,the primary neurologicaltoxicity of the compoundsdetermined byt he rotarod test ispresented in Table 4.…”
Section: 2anticonvulsantactivitymentioning
confidence: 99%
“…Inrecenty ears,one of the common strategiesfort he developmentof the newAEDsismolecularmodification of the knownd rugsormoleculesw ithanticonvulsant activity.Anilide,one of the pharmacophoresw ithanticonvulsantactivity against maximale lectroshockseizures(MES)wass tudied extensivelybyt he research groupsof Clarkand Vamecq [8][9][10][11][12][13][14][15][16].Ho etal. alsostudied anilide derivativesand reported N -(2,6-dimethylphenyl)piperidine-2-carboxamide ast he most active molecule [17].Inthe lightof thesestudies,anti-MES activity of anilide pharmacophorei sdepending on the substitution patternand the natureo fthe substituent on the N -phenylring.…”
Section: Introductionmentioning
confidence: 99%
“…However, several studies suggest that primary metabolites of benzoxazoles are amid derivatives, which form from the hydrolysis of the oxazole ring . As with benzoxazoles, it has been reported that benzamide and phenylacetamide derivatives exhibit various antimicrobial, antiviral, analgesic, anticonvulsant, antihelmintic, and especially anticancer biological properties. Imatinib, structurally a phenyl benzamide derivative, is a well‐known first targeted anticancer agent and a small molecule kinase inhibitor used to treat certain types of cancer.…”
Section: Introductionmentioning
confidence: 99%
“…The latter 4-nitro-N-phenylbenzamide was also found to be active against seizures induced by scPTZ and was selected for further evaluation in rats dosed orally. In these conditions, N-(2-clhoro-6-methylphenyl)-4-nitrobenzamidc was found to be, three times more active than phenytoin and 4-ainino-N-(2,6-dimethylphenyl) benzamide, two times more potent in the MES test [6]. commercialized in Italy until 1985 with the brand name of Synovial, that has been widely used to treat arthritic patient.…”
Section: Biological Profile Anticonvulsant Activitymentioning
confidence: 99%